NorthWest Biotherapeutics Inc (NWBO): The Phase III clinical trial is not halt...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

News Focus

News Focus

NorthWest Biotherapeutics Inc (NWBO)

Keep Last Read

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	64
Posts	3399
Boards Moderated	0
Alias Born	07/26/2012

Re: reg2015 post# 76094

Saturday, 09/24/2016 4:10:50 PM

Saturday, September 24, 2016 4:10:50 PM

The Phase III clinical trial is not halt, just the patient enrolling is halted. The phase III clinical trial is still on going. They don't need anymore patients. The P3 clinical trial is near completion. IMO it is almost ready for FDA inspection and approval.

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent NWBO News

Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/26/2025 05:15:34 AM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/31/2025 09:23:24 PM

More NWBO News

InvestorsHub NewsWire

Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM

DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM

Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM

C2 Blockchain Reports 803 Million DOG (Bitcoin) Holdings Following Strategic Accumulation of Bitcoin-Native Digital Assets • CBLO • Mar 10, 2026 8:00 AM

RENI Completes Due Diligence on Target Acquisition; Confirms Strong Asset Base and Operational Performance • RENI • Mar 5, 2026 10:15 AM

BlackStar Engages in Talks with U.S. Senate Banking Committee Team Covering the Digital Asset Market Clarity Act • BEGI • Mar 4, 2026 4:47 PM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow